The Department of Defense (DoD) offers this grant to fund high-impact research aimed at qualifying or validating prostate cancer biomarkers. This grant is for the purpose of accelerating the translation of these biomarkers into clinical practice. Priority is given to projects studying multiple biomarkers and fostering multi-institutional collaborations. Applicants must submit preliminary data demonstrating the biomarker’s suitability for clinical application and confirm the availability of samples and data, ideally leveraging existing biospecimen banks. Awarded studies are expected to commence within six months.
Opportunity ID: 156453
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-12-PCRP-BDA |
| Funding Opportunity Title: | DoD Prostate Cancer Biomarker Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 20, 2012 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Aug 23, 2012 |
| Current Closing Date for Applications: | Aug 23, 2012 |
| Archive Date: | Sep 22, 2012 |
| Estimated Total Program Funding: | $3,600,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | Supports high-impact research aimed at qualifying or validating biomarkers for rapid transfer to clinical practice for prostate cancer. Projects studying multiple biomarkers are highly encouraged. Multi-institutional efforts are highly encouraged. Presentation of preliminary data demonstrating the suitability of the biomarker(s) for further testing toward clinical application is required. PIs must demonstrate availability and accessibility of samples and /or data, and are encouraged to leverage pre-existing resources, e.g., biospecimen banks Studies are expected to be initiated within 6 months of the award date. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk: 301-682-5507
Email:help@cdmrp.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 156453 Full Announcement-1 -> fy12 cdmrp gai final 12mar2012.pdf
Folder 156453 Full Announcement-1 -> pcrp_fy12_bda_ pa_gg.pdf
Packages
| Agency Contact Information: | CDMRP Help Desk: 301-682-5507 Email: help@cdmrp.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00108790 | Mar 20, 2012 | Aug 23, 2012 | View |
Package 1
Mandatory forms
156453 RR_SF424_1_2-1.2.pdf
156453 PerformanceSite_1_4-1.4.pdf
156453 RR_Budget-1.1.pdf
156453 RR_KeyPersonExpanded_1_2-1.2.pdf
Optional forms
156453 RR_SubawardBudget30-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
